Unique case of total artificial cardiac support in failed Fontan circulation after cardiectomy: Is continuous flow better than pulsatile flow?
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We report a case of total cardiectomy with implantation of a left ventricular assist device (VAD) for postcardiotomy Fontan circulation failure. This unique experience provides valuable insights into the physiologic consequences of pulsatile versus continuous flow (CF) VADs in the singleventricle circulation.
CLINICAL SUMMARY
A male infant with tricuspid atresia 1C underwent pulmonary artery banding shortly after birth, followed by a bidirectional cavopulmonary anastomosis at 6 months. At 2.8 years of age, he underwent an extracardiac fenestrated Fontan procedure and was extubated in the operating room. Excessive chest tube losses prompted reexploration 8 hours after surgery. Uncontrollable hemorrhage from an extensive myocardial hematoma was identified. The patient was placed on cardiopulmonary bypass; however, further measures to control bleeding from a myocardial dehiscence along the diaphragmatic surface of the heart were unsuccessful. The heart was completely excised along the atrioventricular groove while maintaining the Fontan pathway intact, and the ascending aorta was transected at the sinotubular junction with removal of all native valves. A 30-mm Gelweave graft (Terumo Cardiovascular Systems Corporation, Ann Arbor, Mich) was anastomosed to the left atrial cuff, forming a reservoir for pulmonary venous return and connected to a 9-mm Berlin Heart (BH) inflow cannula. A 16-mm Gore-Tex graft (W. L. Gore & Associates, Flagstaff, Ariz) was sewn end-to-end to the ascending aorta, permitting placement of a 6-mm BH outflow cannula. A CentriMag CF pump (Thoratec Corporation, Pleasanton, Calif) was connected to the BH cannulas as an interim device during the wait for patient stabilization. The CentriMag resulted in stable flow, with a mean arterial pressure of 50 to 70 mm Hg and a central venous pressure of 12 to 14 mm Hg. An 80-mL saline tissue expander was placed within the empty pericardial sac to maintain space for future transplantation.
The patient was extubated, alert, and interactive on day 6 of support. At day 10, a mobile thrombus in the circuit necessitated pump change. In light of the patient's hemodynamic stability and improving end organ function, he the pump was converted to a pulsatile flow BH EXCOR left ventricular assist device.
During the ensuing weeks, this patient acquired progressive pulmonary edema and vascular congestion refractory to diuresis. On day 28 of EXCOR support, he was reintubated for respiratory failure and subsequently required venovenous extracorporeal membrane oxygenation. Cardiac catheterization on day 37 of EXCOR support demonstrated an extensive plexus of decompressing venous collaterals and an elevated Fontan pressure of 24 mm Hg. Angiography demonstrated unobstructed pulmonary venous drainage to the Gelweave reservoir. Transcatheter coil occlusion of the collaterals transiently improved systemic oxygenation. Attempted optimization of EXCOR settings was subsequently performed under transesophageal echocardiographic guidance with interrogation of the pulmonary venous Doppler profiles. Figure 1 demonstrates the pulmonary venous Doppler profile with significant reversal of blood flow into the pulmonary veins during pump systole as a result of the absence of compliant native left atrial tissue and intact BH valves, despite a calculated cardiac index of 4.1 L/(min $ m 2 ). To improve pulmonary and systemic venous congestion, VAD support was converted back to the CentriMag on day 44 of EXCOR support. The CentriMag CF pump resulted in an instantaneous decrease in Fontan pressures from 24 to 12 mm Hg and clearing of the pulmonary congestion, allowing venovenous extracorporeal membrane oxygenation decannulation the next day. Unfortunately, on day 10 of CentriMag support, at a total of 54 days of VAD support, the patient had catastrophic mesenteric ischemia necessitating withdrawal of care.
DISCUSSION
VAD support with an intact Fontan pathway is possible after cardiectomy with currently available devices in children with careful consideration of device type, either continuous or pulsatile flow. Unique to this case was removal of the entire myocardial mass and replacement of the collecting chambers with noncompliant prosthetic material. This resulted in a physiologic situation similar to that of a failed Fontan circulation, with severe diastolic dysfunction and preserved systolic function. As such, use of a pulsatile-flow VAD was ineffective in unloading the pulmonary venous circulation, despite augmenting flow rates. The noncompliant Gelweave pulmonary venous reservoir attached to the fixed-volume EXCOR did not have sufficient capacity to ensure adequate decompression of the pulmonary veins, resulting in pulmonary edema, elevated Fontan pressures, and systemic venous hypertension. This was almost immediately rectified with conversion back to a continuous-flow device. Echocardiography proved useful in identifying this problem.
Successful use of pulsatile-flow VADs in failed Fontan circulations has been reported in the setting of systolic ventricular dysfunction. Fontan failure with elevated systemic venous pressures and diastolic dysfunction, however, may be better supported with CF devices. In this setting, we recommend support with a short-term CF pump (CentriMag), connected to BH cannulas for smaller patients, and an intracorporeal CF pump (HeartWare HVAD; International, Inc, Framingham, Mass) in larger patients (>15 kg). Further investigation is needed to determine optimal VAD support to suit the physiologic constraints of singleventricle circulation. 
